AI assistant
Sending…
Imunon, Inc. — Director's Dealing 2018
Oct 3, 2018
35124_dirs_2018-10-03_4cdc0213-7048-41d2-a3a1-b9db1f07aeaa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2018-10-02
Reporting Person: Hooper Robert W (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-10-02 | Celsion Corporation Common Stock | P | 5100 | $2.70 | Acquired | 20787 | Direct |
| 2018-10-03 | Celsion Corporation Common Stock | P | 4900 | $2.70 | Acquired | 25687 | Direct |
Footnotes
F1: The shares were purchased on the open market.
More from Imunon, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Annual Report
2026
May 4
Regulatory Filings
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Feb 18